Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope

Task Toyoda; Zoe Armitstead; Sampada Bhide; Serge Engamba; Emma Henderson; Claire Jones; Pieter MacKeith; Janice Maddock; Gary Reynolds; Nicola Scrafton; Manil Subesinghe; Sujith Subesinghe; Helen Twohig; Sarah L. Mackie; Max Yates

doi:10.1093/rap/rkae002

Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope

Task Toyoda, Zoe Armitstead, Sampada Bhide, Serge Engamba, Emma Henderson, Claire Jones, Pieter MacKeith, Janice Maddock, Gary Reynolds, Nicola Scrafton, Manil Subesinghe, Sujith Subesinghe, Helen Twohig, Sarah L. Mackie, Max Yates

Research output: Contribution to journal › Review article › peer-review

3 Downloads (Pure)

Abstract

The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological and non-pharmacological management of adults with PMR. This guideline is aimed at healthcare professionals in the UK who directly care for people with PMR, including general practitioners, rheumatologists, nurses, physiotherapists, occupational therapists, pharmacists, psychologists and other health professionals. It will also be relevant to people living with PMR and organisations that support them in the public and third sector, including charities and informal patient support groups. This guideline will be developed using the methods and processes outlined in the BSR Guidelines Protocol. Here we provide a brief summary of the scope of the guideline update in development.

Original language	English
Article number	rkae002
Journal	Rheumatology Advances in Practice
Volume	8
Issue number	1
Early online date	14 Feb 2024
DOIs	https://doi.org/10.1093/rap/rkae002
Publication status	Published - 2024

Keywords

management
polymyalgia rheumatica
treatment

Access to Document

10.1093/rap/rkae002Licence: CC BY

Toyoda_2024_RheumatologyAdvancesInPractices_rkae002Final published version, 932 KBLicence: CC BY

Cite this

Toyoda, T., Armitstead, Z., Bhide, S., Engamba, S., Henderson, E., Jones, C., MacKeith, P., Maddock, J., Reynolds, G., Scrafton, N., Subesinghe, M., Subesinghe, S., Twohig, H., Mackie, S. L., & Yates, M. (2024). Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 8(1), [rkae002]. https://doi.org/10.1093/rap/rkae002

@article{bf43b1d0783a4203b2ff2e61d7219b7a,

title = "Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope",

abstract = "The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological and non-pharmacological management of adults with PMR. This guideline is aimed at healthcare professionals in the UK who directly care for people with PMR, including general practitioners, rheumatologists, nurses, physiotherapists, occupational therapists, pharmacists, psychologists and other health professionals. It will also be relevant to people living with PMR and organisations that support them in the public and third sector, including charities and informal patient support groups. This guideline will be developed using the methods and processes outlined in the BSR Guidelines Protocol. Here we provide a brief summary of the scope of the guideline update in development.",

keywords = "management, polymyalgia rheumatica, treatment",

author = "Task Toyoda and Zoe Armitstead and Sampada Bhide and Serge Engamba and Emma Henderson and Claire Jones and Pieter MacKeith and Janice Maddock and Gary Reynolds and Nicola Scrafton and Manil Subesinghe and Sujith Subesinghe and Helen Twohig and Mackie, {Sarah L.} and Max Yates",

note = "Funding Information: This work was supported by BSR. No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article. S.L.M. is supported by the Leeds Biomedical Research Centre. ",

year = "2024",

doi = "10.1093/rap/rkae002",

language = "English",

volume = "8",

journal = "Rheumatology Advances in Practice",

issn = "2514-1775",

publisher = "Oxford University Press",

number = "1",

}

Toyoda, T, Armitstead, Z, Bhide, S, Engamba, S, Henderson, E, Jones, C, MacKeith, P, Maddock, J, Reynolds, G, Scrafton, N, Subesinghe, M, Subesinghe, S, Twohig, H, Mackie, SL & Yates, M 2024, 'Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope', Rheumatology Advances in Practice, vol. 8, no. 1, rkae002. https://doi.org/10.1093/rap/rkae002

TY - JOUR

T1 - Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope

AU - Toyoda, Task

AU - Armitstead, Zoe

AU - Bhide, Sampada

AU - Engamba, Serge

AU - Henderson, Emma

AU - Jones, Claire

AU - MacKeith, Pieter

AU - Maddock, Janice

AU - Reynolds, Gary

AU - Scrafton, Nicola

AU - Subesinghe, Manil

AU - Subesinghe, Sujith

AU - Twohig, Helen

AU - Mackie, Sarah L.

AU - Yates, Max

N1 - Funding Information: This work was supported by BSR. No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article. S.L.M. is supported by the Leeds Biomedical Research Centre.

PY - 2024

Y1 - 2024

N2 - The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological and non-pharmacological management of adults with PMR. This guideline is aimed at healthcare professionals in the UK who directly care for people with PMR, including general practitioners, rheumatologists, nurses, physiotherapists, occupational therapists, pharmacists, psychologists and other health professionals. It will also be relevant to people living with PMR and organisations that support them in the public and third sector, including charities and informal patient support groups. This guideline will be developed using the methods and processes outlined in the BSR Guidelines Protocol. Here we provide a brief summary of the scope of the guideline update in development.

AB - The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological and non-pharmacological management of adults with PMR. This guideline is aimed at healthcare professionals in the UK who directly care for people with PMR, including general practitioners, rheumatologists, nurses, physiotherapists, occupational therapists, pharmacists, psychologists and other health professionals. It will also be relevant to people living with PMR and organisations that support them in the public and third sector, including charities and informal patient support groups. This guideline will be developed using the methods and processes outlined in the BSR Guidelines Protocol. Here we provide a brief summary of the scope of the guideline update in development.

KW - management

KW - polymyalgia rheumatica

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85185793921&partnerID=8YFLogxK

U2 - 10.1093/rap/rkae002

DO - 10.1093/rap/rkae002

M3 - Review article

AN - SCOPUS:85185793921

VL - 8

JO - Rheumatology Advances in Practice

JF - Rheumatology Advances in Practice

SN - 2514-1775

IS - 1

M1 - rkae002

ER -

Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope

Abstract

Keywords

Access to Document

Other files and links

Cite this